Effect of inhibition of cholesterol synthetic pathway on the activation of Ras and MAP kinase in mesangial cells
- 15 March 1999
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1449 (2) , 137-149
- https://doi.org/10.1016/s0167-4889(99)00007-5
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Atherogenic lipoproteins and human diseaseCurrent Opinion in Nephrology and Hypertension, 1997
- Role of Platelet-Derived Growth Factor in Renal InjuryAnnual Review of Physiology, 1995
- Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats.Journal of Clinical Investigation, 1993
- Atherogenic Lipoproteins: Mediators of Glomerular InjuryAmerican Journal of Nephrology, 1993
- Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- A Putative Role of Hypercholesterolemia in Progressive Glomerular InjuryAnnual Review of Medicine, 1992
- A Cytosolic Protein Catalyzes the Release of GDP from p21
ras
Science, 1990
- Platelet-derived growth factor receptors in the kidney—Upregulated expression in inflammationKidney International, 1989
- Treatment of hyperlipidemia reduces glomerular injury in obese Zucker ratsKidney International, 1988
- Lipids and Progressive GlomerulosclerosisAmerican Journal of Nephrology, 1988